Alectinib – March 2026

Capsule 150 mg

  • Brand names:
    • Alecensa®
  • Pharmaceutical Company:
    • ROCHE PRODUCTS PTY LTD
  • Condition/Indication: Non-small cell lung cancer (NSCLC)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026